心脏淋巴管的分布、功能和病理意义

doi:10.16098/j.issn.0529-1356.2020.03.027

摘要/Abstract

摘要：

心脏淋巴引流对于维持心肌内微环境稳定起着重要作用。在心肌梗死和心力衰竭等疾病，淋巴管损伤或功能障碍可引起心脏淋巴水肿，从而导致心肌纤维化，加重炎症反应和严重影响心功能。近年来，人们对于心脏淋巴水肿与心脏疾病的相互关系以及心脏淋巴管新生的生理、病理意义的研究非常重视。靶向刺激心脏淋巴管新生可作为缓解心脏淋巴水肿的可靠疗法。然而，刺激心脏淋巴管新生的优化策略有待深入研究。本文主要综述心脏淋巴管的分布和功能特点，讨论心脏淋巴水肿的病理作用，心脏淋巴管新生的机制以及促进心脏淋巴管新生的措施和临床意义。

关键词: 心, 淋巴管, 淋巴水肿, 淋巴管新生

Abstract:

Drainage of lymph plays an important role in maintaining homeostasis of the myocardium. In heart diseases such as myocardial infarction and heart failure, injure or dysfunction of the lymphatic vessels result in cardiac lymphedema, leading to cardiac fibrosis, inflammation and cardiac dysfunction. In recent years, more attention has been put on studying relation of cardiac lymphedema with heart diseases and physiopathologic impacts of cardiac lymphangiogenesis. Targeting cardiac lymphangiogenesis is regarded as a feasible therapy for relieving cardiac lymphedema. However, the optimized strategies to sustainedly release growth factors or drugs and to transplant stem/progenitor cells need to be investigated. This article reviews mainly the characteristics of the distribution and function of the cardiac lymphatic vessels, and discusses the pathologic affects of cardiac lymphedema, the mechanisms of cardiac lymphangiogenesis and clinical impacts of promoting cardiac lymphangiogenesis.

Key words: Heart, Lymphatic vessel, Lymphedema, Lymphangiogenesis

中图分类号:

王海杰谭玉珍. 心脏淋巴管的分布、功能和病理意义[J]. 解剖学报, 2020, 51(3): 469-472.

WANG Hai-jie TAN Yu-zhen. Distribution, function and pathologic impacts of cardiac lymphatic vessels#br#[J]. Acta Anatomica Sinica, 2020, 51(3): 469-472.

参考文献

［1］ Wang HJ, Tan YZh. Lymphangiogenesis and significance in pathogenesis and treatment of the related diseases［J］. Acta Anatomica Sinica, 2007, 38(2): 250-252. (in Chinese)

王海杰，谭玉珍.淋巴管新生及其在疾病发生和治疗中的意义［J］.解剖学报，2007，38（2）：250-252.

［2］ Aspelund A, Robciuc MR, Karaman S, et al. Lymphatic system in cardiovascular medicine［J］. Circ Res, 2016, 118(3): 515-530.

［3］ Norman S, Riley PR. Anatomy and development of the cardiac lymphatic vasculature: its role in injury and disease［J］. Clin Ana, 2016, 29(3): 305-315.

［4］ Loukas M, Abel N, Shane Tubbs R, et al. The cardiac lymphatic system［J］. Clin Anat, 2011, 24(6): 684-691.

［5］ Wang HJ, Tan YZh. Practical Anatomy of the Heart［M］. Shanghai: Fudan University Press, 2007: 134-136. (in Chinese)

王海杰，谭玉珍.实用心脏解剖学［M］.上海：复旦大学出版社，2007：134-136.

［6］ Huang LH, Lavine KJ, Randolph GJ. Cardiac lymphatic vessels, transport, and healing of the infarcted heart［J］. JACC, 2017, 2(4): 477-483.

［7］ Miller AJ. The grossly invisible and generally ignored lymphatics of the mammalian heart［J］. Med Hypotheses, 2011, 76(4): 604-606.

［8］ Kong XQ, Wang LX, Kong DG. Cardiac lymphatic interruption is a major cause for allograft failure after cardiac transplantation［J］. Lympha Res Biol, 2007, 5(1): 45-47.

［9］ Lupinski RW. Aortic fat pad and atrial fibrillation: cardiac lymphatics revisited［J］. ANZ J Surg, 2009, 79(12): 70-74.

［10］ Frangogiannis NG. Regulation of the inflammatory response in cardiac repair［J］. Circ Res, 2012, 110 (1): 159-173.

［11］ Vieira JM, Norman S, Villa Del Campo C, et al. The cardiac lymphatic system stimulates resolution of inflammation following myocardial infarction［J］. J Clin Invest, 2018, 128(8): 3402-3412.

［12］ Feola M, Lefer AM. Alterations in cardiac lymph dynamics in acute myocardial ischemia in dogs［J］. J Surg Res, 1977, 23(5): 299-305.

［13］ Henri O, Pouehe C, Houssari M, et al. Selective stimulation of cardiac lymphangiogenesis reduces myocardial edema and fibrosis leading to improved cardiac function following myocardial infarction［J］. Circulation, 2016, 133(15): 1484-1497.

［14］ Kholová I, Dragneva G, Cermáková P, et al. Lymphatic vasculature is increased in heart valves, ischaemic and inflamed hearts and in cholesterolrich and calcified atherosclerotic lesions［J］. Eur J Clin Invest, 2011, 41(5): 487-497.

［15］ Klotz L, Norman S, Vieira JM, et al. Cardiac lymphatics are heterogeneous in origin and respond to injury［J］. Nature, 2015, 522: 62-67.

［16］ Ishikawa Y, Akishima-Fukasawa Y, Ito K, et al. Lymphangiogenesis in myocardial remodelling after infarction［J］. Histopathology, 2007, 51(3): 345-353.

［17］ Vuorio T, Nurmi H, Moulton K, et al. Lymphatic vessel insufficiency in hypercholesterolemic mice alters lipoprotein levels and promotes atherogenesis［J］. Arterioscler Thromb Vasc Biol, 2014, 34(6): 1162-1170.

［18］ Wang QL, Wang HJ, Li ZH, et al. Mesenchymal stem cell-loaded cardiac patch promotes epicardial activation and repair of the infarcted myocardium［J］. J Cell Mol Med, 2017, 21(9): 1751-1766.

［19］ Trincot CE, Xu W, Zhang H, et al. Adrenomedullin induces cardiac lymphangiogenesis after myocardial infarction and regulates cardiac edema via connexin 43［J］. Circ Res, 2019, 124(1): 101-113.

［20］ Shimizu Y, Polavarapu R, Eskla KL, et al. Impact of lymphangiogenesis on cardiac remodeling after ischemia and reperfusion injury［J］. J Am Heart Assoc, 2018, 7(19): e009565.

［21］ Zhang HF, Wang YL, Tan YZ, et al. Enhancement of cardiac lymphangiogenesis by transplantation of CD34+VEGFR-3+ endothelial progenitor cells and sustained release of VEGFC［J］. Basic Res Cardiol, 2019, 114:43.

［22］ Karaman S, Leppanen VM, Alitalo K. Vascular endothelial growth factor signaling in development and disease［J］. Development, 2018, 145(14): dev151019.

［23］ Cao R, Eriksson A, Kubo H, et al. Comparative evaluation of FGF-2-, VEGF-A-, and VEGF-C-induced angiogenesis, lymphangiogenesis, vascular fenestrations, and permeability［J］. Circ Res, 2004, 94(5): 664-670.

［24］ Kazenwadel J, Harvey NL. Lymphatic endothelial progenitor cells: origins and roles in lymphangiogenesis［J］. Curr Opin Immunol, 2018, 53: 81-87.

［25］ Cimini M, Cannata A, Pasquinelli G, et al. Phenotypically heterogeneous podoplanin-expressing cell populations are associated with the lymphatic vessel growth and fibrogenic responses in the acutely and chronically infarcted myocardium［J］. PLoS One, 2017, 12(3): e0173927.

［26］ Tan YZ, Wang HJ, Zhang MH, et al. CD34+VEGFR-3+ progenitor cells have a potential to differentiate towards lymphatic endothelial cells［J］. J Cell Mol Med, 2014, 18 (3): 422-433.

［27］ Zhang MH, Wang HJ, Tan YZh, et al. Differentiation and biological characteristics of the lymphatic endothelial progenitor cells isolated from umbilical cord blood［J］. Acta Anatomica Sinica, 2006, 37(4): 473-478. (in Chinese)

张美华，王海杰，谭玉珍，等.人脐带血淋巴管内皮祖细胞的分化及其生物学特征［J］.解剖学报，2006，37(4)：473-478.

［28］ Wang GD, Tan YZ, Wang HJ, et al. Autophagy promotes degradation of polyethyleneiminealginate nanoparticles in endothelial progenitor cells［J］. Int J Nanomed, 2017, 12: 6661-6675.

［29］ Liu R, Tan YZh, Wang HJ, et al. Sorling of lymphatic endothelial progenitor cells from canine peripheral blood and their differentiation induction towards endothelial cell［J］. Chinese Journal of Hematology, 2007, 28(3): 169-173. (in Chinese)

刘锐，谭玉珍，王海杰，等.犬外周血淋巴管内皮祖细胞的分选及其向内皮细胞的诱导分化研究［J］.中华血液学杂志，2007，28（3）：169-173.

［30］ Ao H, Tan YZh, Wang HJ, et al. Release of soluble VEGFR-3 from lymphatic endothelial progenitor cells after gene transfection［J］. Acta Laboratorium Animalis Scientia Sinica, 2009, 17(4): 252-257. (in Chinese)

敖红，谭玉珍，王海杰，等.VEGFR3基因转染淋巴管内皮祖细胞后可溶性VEGFR-3蛋白的分泌［J］.中国实验动物学报，2009，17（4）：252-257.

［31］ Li T, Wang GD, Tan YZ, et al. Inhibition of lymphangiogenesis of endothelial progenitor cells with VEGFR-3 siRNA delivered with PEI-alginate nanoparticles［J］. Int J Biol Sci, 2014, 10(2): 160-170.

［32］ Pascual-Gil S, Garbayo E, Díaz-Herráez P, et al. Heart regeneration after myocardial infarction using synthetic biomaterials［J］. J Control Release, 2015, 203:23-38.

［33］ Alitalo K. The lymphatic vasculature in disease［J］. Nat Med, 2011, 17(11): 1371-1380.

［34］ Wang HJ, Tan YZ, Pober JS. The architecture of the lymphatic vessels in the tissues revealed with whole-mount immunostaining［J］. Acta Anatomica Sinica, 2016, 47(3): 421-424. (in Chinese)

王海杰，谭玉珍，Pober JS.整片组织免疫染色显示淋巴管构筑［J］.解剖学报，2016，47（3）：421-424.

［35］ Vuorio T, Tirronen A, Ylä-Herttuala S. Cardiac lymphatics-A new avenue for therapeutics［J］. Trends Endocrinol Metab, 2017, 28(4): 285-296.

[1]	郝永明郭磊周程辉裴汉军李莉赵哲 . 改良腹主动脉缩窄法建立心肌肥厚模型[J]. 解剖学报, 2024, 55(1): 120-124.
[2]	许亚平余悦欣陈金福王柯柯郭志坤 . 高龄大鼠心室肌间质弹性纤维和胶原纤维的结构分布特征及其机制 [J]. 解剖学报, 2023, 54(6): 716-721.
[3]	王柯柯罗欢欢孟祥光王前郭志坤. 心力衰竭大鼠心肌中弹性蛋白和胶原蛋白的表达[J]. 解剖学报, 2022, 53(5): 637-643.
[4]	罗红高歌张光琼刘欢杨红宇沈祥春. 慢病毒转导敲低Smad7表达对大鼠原代心肌成纤维细胞增殖、迁移、细胞表型分化和Ⅰ型胶原蛋白表达的影响[J]. 解剖学报, 2022, 53(5): 578-584.
[5]	胡耀文孙艳荣孙昊哲王文娟张苏欣秦丽华. Nogo蛋白与心肌纤维化关系的研究进展[J]. 解剖学报, 2022, 53(5): 674-679.
[6]	张鑫王绪娇李晶马威范宁徐飞. 3种肥胖指标对云南省纳西族和普米族中心性肥胖的预测及民族间比较[J]. 解剖学报, 2022, 53(3): 374-380.
[7]	花蕾宁姝威王前孟祥光郭志坤. 心力衰竭大鼠心肌组织中神经肽Y、降钙素基因相关肽和诱导型一氧化氮合酶的表达变化 #br# [J]. 解剖学报, 2022, 53(3): 340-346.
[8]	卢芬杨晴邵文君孙振坤王恩漫张伟娜. 微小RNA-98-5p靶向Kruppel样转录因子9对大鼠心肌缺血再灌注损伤的保护作用[J]. 解剖学报, 2022, 53(3): 347-353.
[9]	刘向前周仪梦谢向荣倪进忠杨浩. MiR-9-5p调控瞬时受体电位M7对心肌缺血/再灌注大鼠的保护作用[J]. 解剖学报, 2022, 53(2): 246-253.
[10]	王琰赵育洁李志营王前郭志坤 . CD73对体外大鼠心肌细胞增殖和功能的影响[J]. 解剖学报, 2022, 53(1): 28-34.
[11]	刘梦昕孙昌业李铎任明芬郭志坤. 大鼠成纤维细胞生长因子对心肌成纤维细胞增殖和转分化的作用机制[J]. 解剖学报, 2021, 52(5): 712-719.
[12]	李英谢利德王途赵娟. 多肽类化合物Urantide对动脉粥样硬化大鼠心脏组织中骨桥蛋白和α平滑肌肌动蛋白表达的影响[J]. 解剖学报, 2021, 52(3): 446-452.
[13]	史卓李家慧高静董艳莉任甫文普帅 . 小鼠心肌肥厚枢纽基因的筛选与鉴定[J]. 解剖学报, 2021, 52(3): 391-397.
[14]	张苏欣孙艳荣王文娟孙昊哲胡耀文秦丽华. Nogo在心脏中的分布及其在心血管疾病中的作用[J]. 解剖学报, 2021, 52(3): 495-498.
[15]	覃露芸骆利飞关鹏孙智敏王娜. 黄芪甲苷通过诱导自噬减轻慢性间歇性低氧大鼠心脏损伤[J]. 解剖学报, 2021, 52(2): 270-276.